TMCI - Treace Medical Concepts - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TMCI is currently covered by 5 analysts with an average price target of $4.12. This is a potential upside of $1.44 (53.73%) from yesterday's end of day stock price of $2.68.

Treace Medical Concepts's activity chart (see below) currently has 86 price targets and 59 ratings on display. The stock rating distribution of TMCI is 91.67% HOLD and 8.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.27% with an average time for these price targets to be met of 57 days.

Highest price target for TMCI is $9, Lowest price target is $4, average price target is $5.96.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 10-Nov-2025. First documented stock forecast 18-May-2021.

Best performing analysts who are covering TMCI - Treace Medical Concepts:

Andrew Ranieri Rick Wise Richard Newitter Danielle Antalffy Robbie Marcus Ryan Zimmerman

Currently out of the existing stock ratings of TMCI, 11 are a HOLD (91.67%), 1 are a BUY (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$4

$1.02 (34.23%)

$7

23 days ago
(10-Nov-2025)

6/17 (35.29%)

$0.44 (12.36%)

73

Hold

$5

$2.02 (67.79%)

$8

26 days ago
(07-Nov-2025)

2/5 (40%)

$-1.23 (-19.74%)

34

Hold

$5.85

$2.87 (96.31%)

$8.6

26 days ago
(07-Nov-2025)

3/7 (42.86%)

$-0.38 (-6.10%)

46

Buy

26 days ago
(07-Nov-2025)

1/5 (20%)

$4.48 (33.14%)

120

Hold

$9

$6.02 (202.01%)

$8

9 months 5 days ago
(28-Feb-2025)

7/12 (58.33%)

$0.06 (0.67%)

47

Show more analysts

Please expand the browser size to see the chart

What is TMCI (Treace Medical Concepts) average time for price targets to be met?

On average it took 57 days on average for the stock forecasts to be realized with a an average price target met ratio 42.27

Which analyst has the current highest performing score on TMCI (Treace Medical Concepts) with a proven track record?

DREW RANIERI

Which analyst has the current lower performing score on TMCI (Treace Medical Concepts) with a proven track record?

RYAN ZIMMERMAN

Which analyst has the most public recommendations on TMCI (Treace Medical Concepts)?

Drew Ranieri works at MORGAN STANLEY and has 4585 price targets and 2484 ratings on TMCI

Which analyst is the currently most bullish on TMCI (Treace Medical Concepts)?

Rick Wise with highest potential upside - $6.02

Which analyst is the currently most reserved on TMCI (Treace Medical Concepts)?

Ryan Zimmerman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?